Responses
Section 5: Patient safety and quality assurance
5PSQ-198 Variations in effectiveness and safety of glecaprevir/pibrentasvir among hepatitis C patients with different genotypes: a multi-institutional cohort study in Taiwan
Compose a Response to This Article
Other responses
No responses have been published for this article.